Catherine M. Heinzinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Catherine M. Heinzinger has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Reena Mehra
Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, USA
4 shared publications Alex Milinovich
Department of Quantitative Health Sciences, Cleveland Clinic , Cleveland, OH
3 shared publicationsCinthya Pena Orbea
Sleep Disorders Center, Neurological Institute, Cleveland Clinic , Cleveland, OH
3 shared publications- David R. Van Wagoner
Department of Heart, Blood & Kidney Research, Cleveland Clinic Research, Cleveland Clinic, Cleveland, Ohio, USA
3 shared publications - Matheus Araújo
Sleep Disorders Center, Neurological Institute Cleveland Clinic Foundation, Cleveland, USA
3 shared publications Nancy Foldvary-Schaefer
Sleep Disorders Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA
3 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 7603
A foundation model for sleep-based risk stratification and clinical outcomes
Clinical sleep studies capture multiple physiologic signals, yet interpretation is often reduced to single summary measures of limited prognostic value, such as the apnea–hypopnea index. We present a foundation model that learns rich representations of sleep physiology from more than 10,000 clinical sleep recordings linked to electronic medical records. Here we show that sleep physiology contains latent risk structure invisible to conventional metrics, identifying five patient risk groups with markedly different trajectories for mortality, cardiovascular, and neurological disease. The highest-risk group shows more than double the mortality risk of the lowest, whereas apnea–hypopnea index severity categories show limited predictive value. The framework generalizes to the independent Sleep Heart Health Study, distinguishing high- and low-risk patients despite lower-resolution data. We demonstrate that foundation models recover clinically meaningful risk information embedded in routine sleep recordings that conventional metrics systematically miss, providing a scalable path to precision sleep medicine.
- 3 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 7603
Open AccessA foundation model for sleep-based risk stratification and clinical outcomes
Clinical sleep studies capture multiple physiologic signals, yet interpretation is often reduced to single summary measures of limited prognostic value, such as the apnea–hypopnea index. We present a foundation model that learns rich representations of sleep physiology from more than 10,000 clinical sleep recordings linked to electronic medical records. Here we show that sleep physiology contains latent risk structure invisible to conventional metrics, identifying five patient risk groups with markedly different trajectories for mortality, cardiovascular, and neurological disease. The highest-risk group shows more than double the mortality risk of the lowest, whereas apnea–hypopnea index severity categories show limited predictive value. The framework generalizes to the independent Sleep Heart Health Study, distinguishing high- and low-risk patients despite lower-resolution data. We demonstrate that foundation models recover clinically meaningful risk information embedded in routine sleep recordings that conventional metrics systematically miss, providing a scalable path to precision sleep medicine.
- 4 March 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (6)
Polysomnographic sleep architectural disruption associated with atrial fibrillation development
Study Objectives: To examine the unclear, inconsistent role of sleep architectural disruption in atrial fibrillation (AF) development. Methods: Patients (age ≥ 18 years) who underwent in-laboratory sleep studies at Cleveland Clinic 2000–2015 were examined (follow-up: 7.8 ± 3.5 years). Primary predictors were arousal index and total sleep time. Secondary predictors included sleep efficiency, wakefulness after sleep onset, sleep and REM latency, and percentage of each sleep stage. Predictors were fit to Cox proportional hazard models predicting time from sleep study to AF by diagnosis code. Covariates included demographics, anthropometrics, tobacco use, sleepiness, apnea–hypopnea index, sleep apnea-specific hypoxic impact, cardiovascular risk factors and disease, mood disorders, medications, and positive airway pressure. Results: In our cohort (n = 27 232, age: 49.4 ± 14.5 years, 43.7% male, 73.9% white), 2077 (7.6%) developed incident AF. Arousal index was not associated with AF incidence. For every hour of decreased total sleep time, AF incidence increased 8% (HR = 1.08, 95% CI = 1.04 to 1.11). For every 10-unit decrease in sleep efficiency, AF incidence increased 6% (HR = 1.06, 95% CI = 1.04 to 1.09). For every hour of increased wakefulness after sleep onset, AF incidence increased 11% (HR = 1.11, 95% CI = 1.05 to 1.16). For every 10-unit increase in percent N1, AF incidence increased 6% (HR = 1.06, 95% CI = 1.01 to 1.10). Conclusions: Less sleep time and greater sleep disruption were associated with increased incident AF in this large clinical cohort. These results suggest that sleep macro-architecture can influence AF development. Mechanistic and prospective studies are needed to verify whether sleep disruption is a novel target for AF prevention.
- 4 March 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (6)
Polysomnographic sleep architectural disruption associated with atrial fibrillation development
Study Objectives: To examine the unclear, inconsistent role of sleep architectural disruption in atrial fibrillation (AF) development. Methods: Patients (age ≥ 18 years) who underwent in-laboratory sleep studies at Cleveland Clinic 2000–2015 were examined (follow-up: 7.8 ± 3.5 years). Primary predictors were arousal index and total sleep time. Secondary predictors included sleep efficiency, wakefulness after sleep onset, sleep and REM latency, and percentage of each sleep stage. Predictors were fit to Cox proportional hazard models predicting time from sleep study to AF by diagnosis code. Covariates included demographics, anthropometrics, tobacco use, sleepiness, apnea–hypopnea index, sleep apnea-specific hypoxic impact, cardiovascular risk factors and disease, mood disorders, medications, and positive airway pressure. Results: In our cohort (n = 27 232, age: 49.4 ± 14.5 years, 43.7% male, 73.9% white), 2077 (7.6%) developed incident AF. Arousal index was not associated with AF incidence. For every hour of decreased total sleep time, AF incidence increased 8% (HR = 1.08, 95% CI = 1.04 to 1.11). For every 10-unit decrease in sleep efficiency, AF incidence increased 6% (HR = 1.06, 95% CI = 1.04 to 1.09). For every hour of increased wakefulness after sleep onset, AF incidence increased 11% (HR = 1.11, 95% CI = 1.05 to 1.16). For every 10-unit increase in percent N1, AF incidence increased 6% (HR = 1.06, 95% CI = 1.01 to 1.10). Conclusions: Less sleep time and greater sleep disruption were associated with increased incident AF in this large clinical cohort. These results suggest that sleep macro-architecture can influence AF development. Mechanistic and prospective studies are needed to verify whether sleep disruption is a novel target for AF prevention.
- 17 July 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (9) , 2074-2084
Novel Sleep Phenotypic Profiles Associated With Incident Atrial Fibrillation in a Large Clinical Cohort
- 17 July 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (9) , 2074-2084
Novel Sleep Phenotypic Profiles Associated With Incident Atrial Fibrillation in a Large Clinical Cohort
- Open Access
Neighborhood Disadvantage Association with Sleep Apnea and Longitudinal Cardiovascular Events in a Large Clinical Cohort
Background: The association between neighborhood socioeconomic disadvantage and poor cardiovascular outcomes is well established; however, less is known about its interplay with obstructive sleep apnea. Methods: Adult cardiovascular disease-naïve patients who underwent sleep testing at Cleveland Clinic in Ohio from August of 1998 to August of 2021 were included in this cohort. The primary exposure was Area Deprivation Index (ADI) calculated by national rank, i.e. 25 th , 50 th, and 75 th percentiles; higher quartiles reflecting greater deprivation (ADI-Q1-4) with Q1 as reference. Cox proportional hazard models were used to determine the hazard of composite outcome of major adverse cardiovascular events (MACE), i.e. including heart failure, stroke, atrial fibrillation and coronary artery disease or death, adjusted for demographics, comorbidities, cardiac medications and objective OSA-related measures including of Apnea Hypopnea Index (AHI) and sleep-related hypoxia (percentage of sleep time spent<90%SaO2,T90). Linear models were used to examine the relationship between ADI and OSA-related measures. Interaction terms were tested between ADI and OSA-related measures. Results: Of 72,443 adults age was 50.4±14.2 years, 50.5% were men, and 18.4% Black individuals. The median AHI was 14.3[5.8, 33.3] with a median follow-up of 4.39 [IQR,1.76-7.92] years. The relative incidence of initial MACE in the presence of competing risk of death was 17% higher (HR,1.17[95%CI 1.09-1.27],p<.001) for those living in ADI-Q4. Greater levels of area deprivation were associated with sleep-related hypoxia measures including higher degree of T90(p<.001); lower mean SaO2(p<.001), and lower minimum SaO2(p<.001). Significant interactions between T90 and ADI were observed with the risk of MACE(p=0.002) or death(p=0.005). T90 conferred a 37% increased risk of MACE(HR, 1.37[95%CI:1.23-1.53]) for those living in ADI-Q1; and a 26% increased risk(HR, 1.26[95%CI:1.14-1.38%]) among patients living in ADI-Q4. For individuals living in ADI-Q2 and Q3, T90 conferred a respective 56% and 51% increased risk of death (HR,1.56[95%CI:1.23 - 1.96]; HR, 1.51[95%CI:1.21-1.88]), respectively. Conclusions: Neighborhood disadvantage was associated with an increased risk for MACE or death in this clinical cohort and this association was modified by sleep-related hypoxia. Further research is needed to identify neighborhood-specific social determinants contributing to sleep-cardiovascular health disparities to develop neighborhood-specific interventions. Clinical Perspective: What is new?: This is the largest-to-date longitudinal study using a large clinically phenotyped sample that uncovers the association of neighborhood socioeconomic position and sleep apnea with major cardiovascular events and mortality. In this cohort, patients with increased sleep-related hypoxia living in both extremes of area deprivation had an increased risk for major adverse cardiovascular events, whereas individuals with increased sleep-related hypoxia living in moderate areas of deprivation had an increased risk for death. What Are the Clinical Implications?: Addressing disparities in sleep-related hypoxia may be a modifiable and targetable intervention to decreased overall health disparities cardiovascular health. There is a call to action to develop future studies examining neighborhood-level social determinants of health that influence increased sleep-related hypoxia in patients with sleep apnea to improve cardiovascular outcomes across all populations at risk for health inequities.
Open AccessNeighborhood Disadvantage Association with Sleep Apnea and Longitudinal Cardiovascular Events in a Large Clinical Cohort
Background: The association between neighborhood socioeconomic disadvantage and poor cardiovascular outcomes is well established; however, less is known about its interplay with obstructive sleep apnea. Methods: Adult cardiovascular disease-naïve patients who underwent sleep testing at Cleveland Clinic in Ohio from August of 1998 to August of 2021 were included in this cohort. The primary exposure was Area Deprivation Index (ADI) calculated by national rank, i.e. 25 th , 50 th, and 75 th percentiles; higher quartiles reflecting greater deprivation (ADI-Q1-4) with Q1 as reference. Cox proportional hazard models were used to determine the hazard of composite outcome of major adverse cardiovascular events (MACE), i.e. including heart failure, stroke, atrial fibrillation and coronary artery disease or death, adjusted for demographics, comorbidities, cardiac medications and objective OSA-related measures including of Apnea Hypopnea Index (AHI) and sleep-related hypoxia (percentage of sleep time spent<90%SaO2,T90). Linear models were used to examine the relationship between ADI and OSA-related measures. Interaction terms were tested between ADI and OSA-related measures. Results: Of 72,443 adults age was 50.4±14.2 years, 50.5% were men, and 18.4% Black individuals. The median AHI was 14.3[5.8, 33.3] with a median follow-up of 4.39 [IQR,1.76-7.92] years. The relative incidence of initial MACE in the presence of competing risk of death was 17% higher (HR,1.17[95%CI 1.09-1.27],p<.001) for those living in ADI-Q4. Greater levels of area deprivation were associated with sleep-related hypoxia measures including higher degree of T90(p<.001); lower mean SaO2(p<.001), and lower minimum SaO2(p<.001). Significant interactions between T90 and ADI were observed with the risk of MACE(p=0.002) or death(p=0.005). T90 conferred a 37% increased risk of MACE(HR, 1.37[95%CI:1.23-1.53]) for those living in ADI-Q1; and a 26% increased risk(HR, 1.26[95%CI:1.14-1.38%]) among patients living in ADI-Q4. For individuals living in ADI-Q2 and Q3, T90 conferred a respective 56% and 51% increased risk of death (HR,1.56[95%CI:1.23 - 1.96]; HR, 1.51[95%CI:1.21-1.88]), respectively. Conclusions: Neighborhood disadvantage was associated with an increased risk for MACE or death in this clinical cohort and this association was modified by sleep-related hypoxia. Further research is needed to identify neighborhood-specific social determinants contributing to sleep-cardiovascular health disparities to develop neighborhood-specific interventions. Clinical Perspective: What is new?: This is the largest-to-date longitudinal study using a large clinically phenotyped sample that uncovers the association of neighborhood socioeconomic position and sleep apnea with major cardiovascular events and mortality. In this cohort, patients with increased sleep-related hypoxia living in both extremes of area deprivation had an increased risk for major adverse cardiovascular events, whereas individuals with increased sleep-related hypoxia living in moderate areas of deprivation had an increased risk for death. What Are the Clinical Implications?: Addressing disparities in sleep-related hypoxia may be a modifiable and targetable intervention to decreased overall health disparities cardiovascular health. There is a call to action to develop future studies examining neighborhood-level social determinants of health that influence increased sleep-related hypoxia in patients with sleep apnea to improve cardiovascular outcomes across all populations at risk for health inequities.
- 13 December 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (1) , 65-67
Salient Temporalities of Patient-Reported Sleep Disturbance and Burden of Atrial Fibrillation
- 13 December 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (1) , 65-67
Salient Temporalities of Patient-Reported Sleep Disturbance and Burden of Atrial Fibrillation
- Open Access
- 21 November 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (22) , e031462
Sleep‐Disordered Breathing, Hypoxia, and Pulmonary Physiologic Influences in Atrial Fibrillation
Background: We leverage a large clinical cohort to elucidate sleep‐disordered breathing and sleep‐related hypoxia in incident atrial fibrillation (AF) development given the yet unclear contributions of sleep‐related hypoxia and pulmonary physiology in sleep‐disordered breathing and AF. Methods and Results: Patients who underwent sleep studies at Cleveland Clinic January 2, 2000, to December 30, 2015, comprised this retrospective cohort. Cox proportional hazards models were used to examine apnea hypopnea index, percentage time oxygen saturation 2 , and 1947 (4.6%) developed AF over 5 years. A 10‐unit apnea hypopnea index increase was associated with 2% higher AF risk (hazard ratio [HR], 1.02 [95% CI, 1.00–1.03]). A 10‐unit increase in percentage time oxygen saturation <90% and 10‐unit decreases in mean and minimum oxygen saturation were associated with 6% (HR, 1.06 [95% CI, 1.04–1.08]), 30% (HR, 1.30 [95% CI, 1.18–1.42]), and 9% (HR, 1.09 [95% CI, 1.03–1.15]) higher AF risk, respectively. After adjustment for spirometry (n=9683 with available data), only hypoxia remained significantly associated with incident AF, although all coefficients were stable. Conclusions: Sleep‐related hypoxia was associated with incident AF in this clinical cohort, consistent across 3 measures of hypoxia, persistent after adjustment for pulmonary physiologic impairment. Findings identify a strong role for sleep‐related hypoxia in AF development without pulmonary physiologic interdependence.
- 21 November 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (22) , e031462
Open AccessSleep‐Disordered Breathing, Hypoxia, and Pulmonary Physiologic Influences in Atrial Fibrillation
Background: We leverage a large clinical cohort to elucidate sleep‐disordered breathing and sleep‐related hypoxia in incident atrial fibrillation (AF) development given the yet unclear contributions of sleep‐related hypoxia and pulmonary physiology in sleep‐disordered breathing and AF. Methods and Results: Patients who underwent sleep studies at Cleveland Clinic January 2, 2000, to December 30, 2015, comprised this retrospective cohort. Cox proportional hazards models were used to examine apnea hypopnea index, percentage time oxygen saturation 2 , and 1947 (4.6%) developed AF over 5 years. A 10‐unit apnea hypopnea index increase was associated with 2% higher AF risk (hazard ratio [HR], 1.02 [95% CI, 1.00–1.03]). A 10‐unit increase in percentage time oxygen saturation <90% and 10‐unit decreases in mean and minimum oxygen saturation were associated with 6% (HR, 1.06 [95% CI, 1.04–1.08]), 30% (HR, 1.30 [95% CI, 1.18–1.42]), and 9% (HR, 1.09 [95% CI, 1.03–1.15]) higher AF risk, respectively. After adjustment for spirometry (n=9683 with available data), only hypoxia remained significantly associated with incident AF, although all coefficients were stable. Conclusions: Sleep‐related hypoxia was associated with incident AF in this clinical cohort, consistent across 3 measures of hypoxia, persistent after adjustment for pulmonary physiologic impairment. Findings identify a strong role for sleep‐related hypoxia in AF development without pulmonary physiologic interdependence.